Dow Down 0.00% Nasdaq Down 0.12%

TapImmune, Inc. (TPIV)

-Other OTC
0.66 Up 0.03(4.76%) 9:32AM EDT
Prev Close:0.63
Open:0.66
Bid:N/A
Ask:N/A
1y Target Est:6.97
Beta:2.04
Next Earnings Date:N/A
Day's Range:0.66 - 0.66
52wk Range:0.66 - 7.00
Volume:1,000
Avg Vol (3m):24,653
Market Cap:12.59M
P/E (ttm):N/A
EPS (ttm):-5.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TPIV

Comparison

Symbol% ChgMkt Cap
TPIVUp 4.76%12.59M
DNDNDown 2.04%231.44M
GSKDown 0.56%110.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.21
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

TapImmune Inc., clinical-stage immunotherapy company, develops peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback